v3.24.2.u1
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Jul. 31, 2024
Jul. 31, 2023
Operating activities:        
Net loss $ (18,012) $ (36,767) $ (37,734) $ (74,298)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Depreciation and amortization 7,303 6,781 13,976 13,771
Stock-based compensation expense 16,448 18,648 33,288 35,786
Amortization of deferred financing costs and debt discount 51 84 112 169
Cost of Phreesia hardware purchased by customers 334 234 677 650
Deferred contract acquisition costs amortization 192 280 384 620
Non-cash operating lease expense 188 109 361 342
Deferred taxes 56 (75) 119 142
Changes in operating assets and liabilities:        
Accounts receivable 4,976 (832) 3,583 (2,370)
Prepaid expenses and other assets 2,867 (383) 3,281 769
Deferred contract acquisition costs (213) 0 (213) 0
Accounts payable 1,186 568 (1,750) (2,415)
Accrued expenses and other liabilities (1,392) 4,239 (2,547) 6,061
Lease liabilities (201) (405) (420) (652)
Deferred revenue (2,722) (1,812) (2,777) (1,565)
Net cash provided by (used in) operating activities 11,061 (9,331) 10,340 (22,990)
Investing activities:        
Acquisitions, net of cash acquired 0 (3,873) 0 (3,873)
Capitalized internal-use software (2,976) (5,088) (7,546) (9,820)
Purchases of property and equipment (4,427) (755) (5,303) (2,102)
Net cash used in investing activities (7,403) (9,716) (12,849) (15,795)
Financing activities:        
Proceeds from issuance of common stock upon exercise of stock options 219 426 566 675
Treasury stock to satisfy tax withholdings on stock compensation awards 0 (3,775) 0 (10,725)
Proceeds from employee stock purchase plan 690 896 1,603 1,863
Finance lease payments (1,995) (1,983) (3,275) (3,427)
Constructive financing 0 1,688 0 1,688
Principal payments on financing agreements (295) (45) (584) (45)
Debt issuance costs and loan facility fee payments 0 (250) (152) (250)
Financing payments of acquisition-related liabilities 0 0 (1,364) 0
Net cash used in financing activities (1,381) (3,043) (3,206) (10,221)
Effect of exchange rate changes on cash and cash equivalents (6) 0 (7) 0
Net increase (decrease) in cash and cash equivalents 2,271 (22,090) (5,722) (49,006)
Cash and cash equivalents – beginning of period 79,527 149,767 87,520 176,683
Cash and cash equivalents – end of period 81,798 127,677 81,798 127,677
Supplemental information of non-cash investing and financing information:        
Right of use assets acquired in exchange for operating lease liabilities 1,194 0 1,958 0
Property and equipment acquisitions through finance leases 333 0 6,862 7,067
Purchase of property and equipment and capitalized software included in current liabilities 1,517 1,509 1,517 1,509
Capitalized stock-based compensation 315 377 663 714
Issuance of stock to settle liabilities for stock-based compensation 1,649 1,924 7,826 7,221
Issuance of stock as consideration in business combinations 0 4,676 0 4,676
Issuance of liabilities as consideration in business combinations 0 91 0 91
Capitalized software acquired through vendor financing 0 2,047 0 2,047
Cash paid for:        
Interest 381 296 864 354
Income taxes $ 417 $ 13 $ 2,010 $ 53